entertainment -WSS

entertainment

author：hotspot 2025-09-06 03:28:36 - browse：86343

Adobe

You didn’t need machine learning to make one prediction about the year’s biggest conference for health care investors, which was held in San Francisco last week. It was going to rain.

Recursion, a biotechnology firm that uses machine learning for drug development and that was announcing that it is rolling out AI-driven drug discovery software with tech giant Nvidia, decided to seize the moment. As the heavens opened, Recursion employees handed out black umbrellas emblazoned with the Recursion logo and lined with neon images of cells. It was one of a series of publicity grabs from the company, including a satellite event featuring Nvidia’s famous CEO, Jensen Huang, who has become a Wall Street rock star as his company’s stock has exploded due to rising expectations for AI, reaching a $1 trillion market value, the sixth highest in the world.

Seeing the square outside the Westin St. Francis, where the J.P. Morgan Healthcare Conference has been held for 42 years, fill with Recursion’s umbrellas was a little like seeing the message that AI was ready for its debut come to life. But it was also true that not everyone was ready to embrace that message.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Hearing on Medicare drug price negotiation gets unusually heated

WSS

Intarcia’s device

Akili, maker of video game for ADHD, to be acquired for 34 million

Drug for rare kidney disease narrowly misses mark in clinical trial

Latest bird flu infection made farmworker sicker than earlier cases

Heat waves linked to early deliveries, preterm births in new study

Readout LOUD podcast: possible new ALS drug, artificial wombs

focus

entertainment

hotspot

New air purifier tech could be key to improving indoor air quality

Biotech stock slump in 2023: awaiting the turnaround

United colonoscopy coverage change 'may cost lives,' doctors say

Health insurers say they are turning to AI to cut costs, improve care

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Lab trade group sues FDA to halt regulation of lab

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Stigma and the return of syphilis

The cancer drug shortage isn’t new — and neither are the solutions

Biohaven protein

focus

Emergency workers more likely to restrain Black patients: study

Addiction doctors spar with methadone clinics over legislation

Senators: Long

Antibiotic resistance nearly killed me, so I'm raising awareness of it

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

Hearing on Medicare drug price negotiation gets unusually heated

entertainment

Wikipedia

focus

explore